Is Sodium Valproate, an HDAC inhibitor, associated with reduced risk of stroke and myocardial infarction? A nested case–control study

BACKGROUND: This study aimed to evaluate whether treatment with sodium valproate (SV) was associated with reduced risk of stroke or myocardial infarction (MI). METHODS: Electronic health records data were extracted from Clinical Practice Research Database for participants ever diagnosed with epileps...

Descripción completa

Detalles Bibliográficos
Autores principales: Dregan, Alex, Charlton, Judith, Wolfe, Charles D A, Gulliford, Martin C, Markus, Hugh S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2014
Materias:
Original Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4312949/
https://www.ncbi.nlm.nih.gov/pubmed/24890032
http://dx.doi.org/10.1002/pds.3651

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4312949/
https://www.ncbi.nlm.nih.gov/pubmed/24890032
http://dx.doi.org/10.1002/pds.3651

Ejemplares similares